Plasma concentrations of disodium cromoglycate after various inhalation methods in healthy subjects

Article date: August 1999

By: Y. Kato, K. Muraki, M. Fujitaka, N. Sakura, K. Ueda, in Volume 48, Issue 2, pages 154-157

Aims To compare the plasma concentrations of disodium cromoglycate (DSCG) following various inhalation procedures in healthy volunteers.

Methods Nine healthy subjects inhaled 2 mg of aerosol, 20 mg of nebuliser solution only, 20 mg of nebuliser solution mixed with isotonic saline, or 20 mg of nebuliser solution mixed with saline and procaterol, a β2‐adenoceptor agonist, on separate occasions 2–3 weeks apart. Plasma concentrations of DSCG were determined by high‐performance liquid chromatography (h.p.l.c.).

Results The peak plasma concentrations of DSCG were 1.5±0.7 (range 0.4–2.4) ng ml−1 in the aerosol group, 8.8±6.2 (range 5.3–19.9) ng ml−1 in the nebuliser solution only group, 17.2±16.3 (range 5.0–38.6) ng ml−1 in the nebuliser solution plus isotonic saline group, and 24.5±11.9 (range 10.2–44.9) ng ml−1 in the nebuliser solution plus saline and procaterol group. Thus subjects who used the nebuliser had markedly higher plasma concentrations of DSCG than subjects who used the aerosol inhaler.

Conclusions These findings may have important implications for the evaluation of inhalation treatment with DSCG for bronchial asthma.

DOI: 10.1046/j.1365-2125.1999.00979.x

View this article